Glucose oxidase (GOD) was covalently immobilized on the electroactive polyaniline (PAN) film with surface-grafted acrylic acid (AAc) polymer through the amide linkage formation between amino groups of GOD and the carboxyl groups of the grafted AAc polymer chains in the presence of a water-soluble carbodiimide. The surface structure and composition of the graft-modified and enzyme-functionalized PAN films were characterized by angle-resolved X-ray photoelectron spectroscopy (XPS). The amounts of immobilized GOD and its activity were also investigated. It was shown that the amount of immobilized GOD increased linearly with the concentration of surface-grafted AAc polymer chains. The decrease in activity of the immobilized GOD was considered to be due to, among other factors, the reduced accessibility of glucose molecules to the active sites of the enzyme and the conformational change of the GOD molecules as a result of the covalent immobilization. However, the immobilized enzyme was less sensitive to thermal inactivation as compared to that of the free form. The optimum pH value of GOD was not affected by the immobilization reaction and the pH stability range was considerably widened. The immobilized GOD also exhibits a significantly improved stability during storage in buffer solution over that of the free enzyme.

Acrylic Resins↗

PubMedDate not supplied

Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine.

The immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine given in doses of 0.6 microgram, 1.25 microgram, 2.5 micrograms and 5.0 micrograms were studied in 4 comparable groups of children aged 1-12 years. All children received three doses of vaccine at time 0, 1 month and 5 months. Immunogenicity appeared to be satisfactory in all 4 groups of children. In the early phase of the study, a dose-response relationship was observed but there was no significant difference in the geometric mean titre among all 4 groups for any period studied. Antibody levels peaked at 9 months, declining thereafter. The geometric mean titre one year after the first vaccine dose was not significantly lower than that at the peak (9 months) in any individual group studied. The second year geometric mean titre was similar in all 4 groups and lower than that of the first year. Sero-conversion with antibody titres greater than or equal to 10 mIU/ml was 100% in the 5.0 micrograms group and greater than 90% in the other 3 groups. There were no adverse reactions of any significance. The immunogenicity of recombinant yeast-derived hepatitis B vaccine was found to be adequate even at as low a dosage as 0.6 microgram when administered in a 3-dose regimen.

Child↗

PubMedDate not supplied